Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Activation of the receptor for advanced glycation end products (RAGE) exacerbates experimental autoimmune myasthenia gravis symptoms.

Mu L, Zhang Y, Sun B, Wang J, Xie X, Li N, Zhang J, Kong Q, Liu Y, Han Z, Wang G, Fu Z, Yu B, Li G, Li H. Activation of the receptor for advanced glycation end products (RAGE) exacerbates experimental autoimmune myasthenia gravis symptoms. Clin Immunol. 2011 Oct; 141(1):36-48.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.